Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nanoparticles | 20 | 2024 | 1943 | 3.160 |
Why?
|
Nanotechnology | 11 | 2012 | 709 | 1.820 |
Why?
|
Drug Carriers | 8 | 2019 | 709 | 1.650 |
Why?
|
Antineoplastic Agents | 22 | 2019 | 13630 | 1.460 |
Why?
|
Neovascularization, Physiologic | 9 | 2012 | 1336 | 1.390 |
Why?
|
Cisplatin | 8 | 2014 | 1644 | 1.300 |
Why?
|
Nanomedicine | 5 | 2019 | 288 | 1.280 |
Why?
|
Drug Delivery Systems | 11 | 2020 | 2221 | 1.260 |
Why?
|
Neoplasms | 23 | 2021 | 22072 | 1.240 |
Why?
|
Hepatocyte Growth Factor | 6 | 2010 | 267 | 1.180 |
Why?
|
Drug Design | 4 | 2019 | 1061 | 1.080 |
Why?
|
Neovascularization, Pathologic | 8 | 2010 | 2640 | 0.960 |
Why?
|
Nanotubes | 2 | 2021 | 77 | 0.930 |
Why?
|
Cell Communication | 3 | 2021 | 1653 | 0.820 |
Why?
|
Cell Line, Tumor | 26 | 2024 | 16939 | 0.740 |
Why?
|
Bone Cements | 1 | 2022 | 324 | 0.730 |
Why?
|
Coculture Techniques | 4 | 2020 | 1342 | 0.730 |
Why?
|
Enzyme Inhibitors | 6 | 2019 | 3726 | 0.720 |
Why?
|
Nanocapsules | 2 | 2013 | 92 | 0.700 |
Why?
|
Transcytosis | 1 | 2019 | 45 | 0.660 |
Why?
|
Nanotubes, Carbon | 2 | 2010 | 71 | 0.660 |
Why?
|
Endothelial Cells | 7 | 2020 | 3539 | 0.660 |
Why?
|
Mice, Inbred BALB C | 14 | 2020 | 6216 | 0.650 |
Why?
|
Pentose Phosphate Pathway | 1 | 2019 | 126 | 0.650 |
Why?
|
Cytotoxins | 1 | 2019 | 153 | 0.650 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2019 | 210 | 0.610 |
Why?
|
Propionibacterium acnes | 1 | 2018 | 65 | 0.610 |
Why?
|
Angiogenesis Inducing Agents | 3 | 2011 | 278 | 0.600 |
Why?
|
Nanospheres | 2 | 2014 | 21 | 0.580 |
Why?
|
Polyethylene Glycols | 3 | 2013 | 1189 | 0.560 |
Why?
|
Neoplasm Proteins | 5 | 2021 | 3610 | 0.560 |
Why?
|
Doxorubicin | 5 | 2010 | 2209 | 0.550 |
Why?
|
Immunoconjugates | 2 | 2024 | 949 | 0.530 |
Why?
|
Monitoring, Immunologic | 1 | 2016 | 98 | 0.520 |
Why?
|
Immunotherapy | 2 | 2024 | 4642 | 0.500 |
Why?
|
Carcinoma, Lewis Lung | 3 | 2012 | 107 | 0.470 |
Why?
|
Liposomes | 4 | 2016 | 777 | 0.470 |
Why?
|
Angiogenesis Inhibitors | 4 | 2005 | 2049 | 0.470 |
Why?
|
Mice | 32 | 2024 | 81208 | 0.460 |
Why?
|
Platinum | 2 | 2012 | 223 | 0.450 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2014 | 124 | 0.440 |
Why?
|
Endothelium, Vascular | 8 | 2021 | 4433 | 0.440 |
Why?
|
Leukocytes | 1 | 2021 | 2026 | 0.440 |
Why?
|
Embryonic Stem Cells | 2 | 2012 | 1262 | 0.440 |
Why?
|
Fullerenes | 2 | 2010 | 14 | 0.440 |
Why?
|
Animals | 42 | 2024 | 167963 | 0.430 |
Why?
|
Insulin-Like Growth Factor II | 2 | 2012 | 268 | 0.430 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5253 | 0.420 |
Why?
|
Polymers | 4 | 2016 | 1621 | 0.420 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2013 | 124 | 0.410 |
Why?
|
Acne Vulgaris | 1 | 2018 | 355 | 0.410 |
Why?
|
Antibodies | 2 | 2019 | 2421 | 0.400 |
Why?
|
Glycomics | 2 | 2011 | 109 | 0.400 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7408 | 0.390 |
Why?
|
Cell Survival | 11 | 2021 | 5797 | 0.390 |
Why?
|
Chromones | 2 | 2009 | 149 | 0.370 |
Why?
|
Melanoma, Experimental | 3 | 2009 | 562 | 0.370 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1652 | 0.360 |
Why?
|
Organoplatinum Compounds | 1 | 2012 | 410 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2013 | 2448 | 0.350 |
Why?
|
Molecular Structure | 4 | 2019 | 1895 | 0.340 |
Why?
|
Drug Monitoring | 1 | 2016 | 965 | 0.340 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2013 | 379 | 0.340 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 717 | 0.340 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1046 | 0.340 |
Why?
|
Heparitin Sulfate | 1 | 2011 | 224 | 0.340 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2024 | 3584 | 0.330 |
Why?
|
Ticlopidine | 1 | 2014 | 895 | 0.320 |
Why?
|
Mitochondria | 1 | 2021 | 3600 | 0.310 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1796 | 0.300 |
Why?
|
Molecular Targeted Therapy | 4 | 2020 | 2803 | 0.300 |
Why?
|
Anticarcinogenic Agents | 1 | 2009 | 249 | 0.300 |
Why?
|
Models, Theoretical | 2 | 2019 | 3562 | 0.300 |
Why?
|
Morpholines | 2 | 2009 | 583 | 0.300 |
Why?
|
Neoplasms, Experimental | 1 | 2013 | 1229 | 0.300 |
Why?
|
Microsatellite Repeats | 2 | 2007 | 786 | 0.290 |
Why?
|
Glucose | 1 | 2019 | 4351 | 0.290 |
Why?
|
Leukoplakia | 1 | 2007 | 18 | 0.290 |
Why?
|
Protein Processing, Post-Translational | 2 | 2021 | 1974 | 0.290 |
Why?
|
Protein Engineering | 3 | 2019 | 541 | 0.270 |
Why?
|
MutS Homolog 2 Protein | 1 | 2007 | 195 | 0.270 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2012 | 3484 | 0.270 |
Why?
|
Breast Neoplasms | 8 | 2021 | 21025 | 0.260 |
Why?
|
Signal Transduction | 11 | 2016 | 23376 | 0.260 |
Why?
|
Neoplasm Metastasis | 5 | 2021 | 4902 | 0.260 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5251 | 0.260 |
Why?
|
Tissue Engineering | 2 | 2015 | 1870 | 0.250 |
Why?
|
Medical Oncology | 1 | 2017 | 2313 | 0.250 |
Why?
|
Cholesterol | 3 | 2020 | 2924 | 0.250 |
Why?
|
Extracellular Matrix | 2 | 2011 | 1726 | 0.250 |
Why?
|
Molecular Dynamics Simulation | 2 | 2019 | 435 | 0.250 |
Why?
|
Ginsenosides | 1 | 2004 | 13 | 0.240 |
Why?
|
Fibroblast Growth Factors | 1 | 2011 | 869 | 0.240 |
Why?
|
Panax | 1 | 2004 | 28 | 0.240 |
Why?
|
Cells, Cultured | 10 | 2018 | 18957 | 0.230 |
Why?
|
Permeability | 2 | 2018 | 719 | 0.230 |
Why?
|
MAP Kinase Signaling System | 2 | 2009 | 1484 | 0.230 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 1928 | 0.230 |
Why?
|
Oncogenes | 1 | 2009 | 1220 | 0.220 |
Why?
|
Thymidine Phosphorylase | 1 | 2003 | 14 | 0.220 |
Why?
|
Macrophages | 1 | 2018 | 5745 | 0.220 |
Why?
|
Models, Molecular | 4 | 2019 | 5434 | 0.220 |
Why?
|
Chitosan | 1 | 2024 | 131 | 0.210 |
Why?
|
Isoenzymes | 2 | 2005 | 1690 | 0.210 |
Why?
|
Phytotherapy | 1 | 2004 | 295 | 0.200 |
Why?
|
Drug Discovery | 1 | 2010 | 1057 | 0.200 |
Why?
|
Macromolecular Substances | 2 | 2018 | 1433 | 0.200 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 364 | 0.200 |
Why?
|
Humans | 53 | 2024 | 760621 | 0.190 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 3201 | 0.190 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2016 | 730 | 0.190 |
Why?
|
Polyenes | 2 | 2012 | 68 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2003 | 1246 | 0.190 |
Why?
|
Peptides | 1 | 2013 | 4354 | 0.180 |
Why?
|
Umbilical Veins | 3 | 2009 | 426 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5643 | 0.180 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2013 | 507 | 0.180 |
Why?
|
Inhibitory Concentration 50 | 2 | 2012 | 465 | 0.180 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 673 | 0.180 |
Why?
|
DNA Glycosylases | 1 | 2021 | 124 | 0.170 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18137 | 0.170 |
Why?
|
Lymphokines | 1 | 2003 | 927 | 0.170 |
Why?
|
Kidney | 2 | 2012 | 7064 | 0.170 |
Why?
|
rho GTP-Binding Proteins | 1 | 2021 | 277 | 0.170 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13262 | 0.170 |
Why?
|
Alginates | 1 | 2021 | 248 | 0.170 |
Why?
|
Chemical Phenomena | 1 | 2019 | 508 | 0.170 |
Why?
|
Insulin Resistance | 1 | 2013 | 3959 | 0.170 |
Why?
|
Drug Stability | 1 | 2019 | 290 | 0.160 |
Why?
|
Tumor Cells, Cultured | 5 | 2021 | 6131 | 0.160 |
Why?
|
Microtechnology | 1 | 2019 | 70 | 0.160 |
Why?
|
Algorithms | 2 | 2016 | 13981 | 0.160 |
Why?
|
Deoxycytidine | 2 | 2013 | 873 | 0.160 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22023 | 0.160 |
Why?
|
Vesicular Transport Proteins | 1 | 2021 | 374 | 0.160 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 400 | 0.150 |
Why?
|
Biofilms | 1 | 2022 | 621 | 0.150 |
Why?
|
Carrier Proteins | 2 | 2012 | 4938 | 0.150 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 114 | 0.150 |
Why?
|
Cytoskeleton | 2 | 2021 | 1167 | 0.150 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 186 | 0.150 |
Why?
|
Models, Biological | 4 | 2016 | 9467 | 0.150 |
Why?
|
Stem Cells | 1 | 2011 | 3523 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 423 | 0.150 |
Why?
|
Antibody Specificity | 1 | 2019 | 1060 | 0.150 |
Why?
|
Phenotype | 6 | 2021 | 16546 | 0.140 |
Why?
|
DNA Gyrase | 1 | 2018 | 85 | 0.140 |
Why?
|
Apoptosis | 6 | 2016 | 9501 | 0.140 |
Why?
|
Phosphorylation | 5 | 2009 | 8313 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2007 | 4024 | 0.140 |
Why?
|
Tissue Distribution | 3 | 2016 | 2262 | 0.140 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2020 | 432 | 0.130 |
Why?
|
Head and Neck Neoplasms | 3 | 2007 | 2882 | 0.130 |
Why?
|
Shear Strength | 1 | 2016 | 161 | 0.130 |
Why?
|
Esterases | 1 | 2016 | 97 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2005 | 2141 | 0.130 |
Why?
|
Melanoma | 3 | 2009 | 5697 | 0.130 |
Why?
|
Administration, Topical | 1 | 2018 | 697 | 0.130 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 979 | 0.130 |
Why?
|
Artificial Intelligence | 1 | 2010 | 2557 | 0.130 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1273 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 998 | 0.130 |
Why?
|
Bibenzyls | 2 | 2005 | 11 | 0.130 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5785 | 0.130 |
Why?
|
Substrate Specificity | 1 | 2019 | 1792 | 0.130 |
Why?
|
Hydrogels | 1 | 2021 | 723 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 9411 | 0.120 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2013 | 697 | 0.120 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3844 | 0.120 |
Why?
|
Rats | 3 | 2022 | 23711 | 0.120 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2005 | 260 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11712 | 0.120 |
Why?
|
Pyridines | 2 | 2004 | 2879 | 0.120 |
Why?
|
Cell Membrane | 2 | 2016 | 3682 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2018 | 65017 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2013 | 2864 | 0.120 |
Why?
|
Stilbenes | 2 | 2005 | 155 | 0.110 |
Why?
|
Zebrafish | 3 | 2010 | 2997 | 0.110 |
Why?
|
Membrane Microdomains | 1 | 2015 | 206 | 0.110 |
Why?
|
Keratinocytes | 1 | 2018 | 792 | 0.110 |
Why?
|
Caspase 3 | 1 | 2016 | 731 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2019 | 1347 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2282 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2003 | 4490 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 544 | 0.110 |
Why?
|
Flavonoids | 2 | 2009 | 445 | 0.110 |
Why?
|
Mice, Nude | 1 | 2019 | 3607 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 944 | 0.110 |
Why?
|
Ascorbic Acid | 1 | 2016 | 655 | 0.110 |
Why?
|
Tumor Burden | 2 | 2016 | 1895 | 0.100 |
Why?
|
Biocompatible Materials | 1 | 2021 | 1689 | 0.100 |
Why?
|
DNA Methylation | 1 | 2007 | 4373 | 0.100 |
Why?
|
Ligands | 1 | 2019 | 3276 | 0.100 |
Why?
|
Podophyllotoxin | 1 | 2012 | 21 | 0.100 |
Why?
|
Maleates | 1 | 2012 | 18 | 0.100 |
Why?
|
Receptor, IGF Type 2 | 1 | 2012 | 35 | 0.100 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2013 | 640 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5791 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1411 | 0.100 |
Why?
|
Succinic Acid | 1 | 2012 | 84 | 0.100 |
Why?
|
Glucosamine | 1 | 2012 | 128 | 0.100 |
Why?
|
Adjuvants, Immunologic | 1 | 2017 | 1039 | 0.100 |
Why?
|
Embryoid Bodies | 1 | 2012 | 65 | 0.100 |
Why?
|
Heparan Sulfate Proteoglycans | 2 | 2009 | 112 | 0.100 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1666 | 0.100 |
Why?
|
Cell Division | 3 | 2003 | 4463 | 0.100 |
Why?
|
Structure-Activity Relationship | 2 | 2010 | 3084 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2039 | 0.100 |
Why?
|
Taxoids | 1 | 2015 | 669 | 0.100 |
Why?
|
Nanostructures | 1 | 2016 | 547 | 0.090 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2203 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2016 | 743 | 0.090 |
Why?
|
Molecular Weight | 1 | 2013 | 2186 | 0.090 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6315 | 0.090 |
Why?
|
Paclitaxel | 2 | 2016 | 1736 | 0.090 |
Why?
|
Cell Line | 2 | 2018 | 15620 | 0.090 |
Why?
|
Phthalazines | 2 | 2004 | 383 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3618 | 0.090 |
Why?
|
Binding Sites | 1 | 2019 | 6048 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 829 | 0.090 |
Why?
|
Base Sequence | 1 | 2021 | 12446 | 0.090 |
Why?
|
Quantitative Structure-Activity Relationship | 1 | 2010 | 28 | 0.090 |
Why?
|
Oligopeptides | 1 | 2016 | 1187 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1055 | 0.090 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2015 | 941 | 0.090 |
Why?
|
Models, Chemical | 1 | 2012 | 614 | 0.090 |
Why?
|
Protein Stability | 1 | 2012 | 566 | 0.090 |
Why?
|
Hydroxides | 1 | 2009 | 46 | 0.090 |
Why?
|
Flow Cytometry | 2 | 2011 | 5870 | 0.080 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 380 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 616 | 0.080 |
Why?
|
Endothelium | 1 | 2012 | 764 | 0.080 |
Why?
|
Protein Structure, Quaternary | 1 | 2010 | 428 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2012 | 11481 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2015 | 3094 | 0.080 |
Why?
|
Chromatin | 1 | 2021 | 2938 | 0.080 |
Why?
|
Sulfotransferases | 1 | 2009 | 149 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2011 | 3604 | 0.080 |
Why?
|
Mesoderm | 1 | 2012 | 672 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2651 | 0.080 |
Why?
|
Crystallization | 1 | 2009 | 533 | 0.080 |
Why?
|
Glycocalyx | 1 | 2009 | 94 | 0.080 |
Why?
|
Male | 14 | 2018 | 359744 | 0.080 |
Why?
|
Drug Compounding | 1 | 2009 | 246 | 0.080 |
Why?
|
Molecular Conformation | 1 | 2009 | 548 | 0.080 |
Why?
|
Monocytes | 1 | 2018 | 2575 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 8056 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2138 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 8158 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 621 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1913 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3215 | 0.070 |
Why?
|
Solubility | 1 | 2009 | 1088 | 0.070 |
Why?
|
Female | 12 | 2021 | 391270 | 0.070 |
Why?
|
Regenerative Medicine | 1 | 2011 | 307 | 0.070 |
Why?
|
Carboplatin | 1 | 2010 | 788 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2019 | 3663 | 0.070 |
Why?
|
Transfection | 3 | 2006 | 5781 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2015 | 1347 | 0.070 |
Why?
|
Surface Properties | 1 | 2009 | 1161 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2019 | 10446 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1648 | 0.070 |
Why?
|
Materials Testing | 1 | 2009 | 862 | 0.070 |
Why?
|
Organ Size | 1 | 2011 | 2254 | 0.070 |
Why?
|
Alternative Splicing | 1 | 2010 | 1091 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2005 | 125 | 0.060 |
Why?
|
Spleen | 1 | 2011 | 2298 | 0.060 |
Why?
|
Biological Transport | 1 | 2009 | 2086 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 1617 | 0.060 |
Why?
|
Korea | 1 | 2004 | 96 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 2502 | 0.060 |
Why?
|
Endocytosis | 1 | 2009 | 959 | 0.060 |
Why?
|
Surgical Sponges | 1 | 2004 | 39 | 0.060 |
Why?
|
Americas | 1 | 2004 | 111 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2007 | 1745 | 0.060 |
Why?
|
Guanylate Cyclase | 1 | 2005 | 205 | 0.060 |
Why?
|
Antigens, CD | 1 | 2015 | 4000 | 0.060 |
Why?
|
Computer Simulation | 1 | 2018 | 6218 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4466 | 0.060 |
Why?
|
Lipoxygenase | 1 | 2003 | 72 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4541 | 0.060 |
Why?
|
Drug Implants | 1 | 2004 | 230 | 0.060 |
Why?
|
Cell Cycle | 2 | 2009 | 2934 | 0.060 |
Why?
|
Deoxyribose | 1 | 2003 | 7 | 0.060 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 659 | 0.060 |
Why?
|
Cyclooxygenase 1 | 1 | 2003 | 97 | 0.060 |
Why?
|
DNA Mismatch Repair | 1 | 2007 | 429 | 0.060 |
Why?
|
Ribosemonophosphates | 1 | 2003 | 7 | 0.060 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2003 | 93 | 0.060 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 267 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10827 | 0.050 |
Why?
|
Water | 1 | 2009 | 1407 | 0.050 |
Why?
|
Models, Animal | 1 | 2009 | 2117 | 0.050 |
Why?
|
Breast | 1 | 2012 | 1963 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2003 | 167 | 0.050 |
Why?
|
Aneuploidy | 1 | 2006 | 551 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2004 | 345 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1612 | 0.050 |
Why?
|
Stereoisomerism | 1 | 2003 | 617 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 908 | 0.050 |
Why?
|
Time Factors | 4 | 2015 | 40165 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1741 | 0.050 |
Why?
|
Fluorescence | 1 | 2004 | 751 | 0.050 |
Why?
|
Genomic Instability | 1 | 2006 | 704 | 0.050 |
Why?
|
Laminin | 1 | 2003 | 405 | 0.050 |
Why?
|
Aerosols | 1 | 2004 | 632 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 321 | 0.050 |
Why?
|
Androstadienes | 1 | 2003 | 348 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 748 | 0.050 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 599 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11071 | 0.050 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9530 | 0.050 |
Why?
|
Mouth Neoplasms | 1 | 2006 | 593 | 0.050 |
Why?
|
Chalcones | 1 | 2020 | 29 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 642 | 0.050 |
Why?
|
Invertebrates | 1 | 2021 | 54 | 0.050 |
Why?
|
Particle Size | 2 | 2021 | 1644 | 0.050 |
Why?
|
Heme Oxygenase-1 | 1 | 2003 | 364 | 0.050 |
Why?
|
Biosensing Techniques | 1 | 2007 | 677 | 0.050 |
Why?
|
Genes, Helminth | 1 | 2021 | 146 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2021 | 186 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20080 | 0.040 |
Why?
|
Kupffer Cells | 1 | 2020 | 143 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7588 | 0.040 |
Why?
|
Biological Assay | 1 | 2003 | 630 | 0.040 |
Why?
|
Propionates | 1 | 2020 | 182 | 0.040 |
Why?
|
Species Specificity | 1 | 2004 | 2418 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6068 | 0.040 |
Why?
|
Helminth Proteins | 1 | 2021 | 172 | 0.040 |
Why?
|
Proteoglycans | 1 | 2003 | 801 | 0.040 |
Why?
|
Hepatic Stellate Cells | 1 | 2020 | 119 | 0.040 |
Why?
|
Genes, Homeobox | 1 | 2021 | 284 | 0.040 |
Why?
|
Vertebrates | 1 | 2021 | 228 | 0.040 |
Why?
|
Macrolides | 1 | 2020 | 206 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 666 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4312 | 0.040 |
Why?
|
Thalidomide | 1 | 2004 | 884 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13451 | 0.040 |
Why?
|
Protein Binding | 1 | 2011 | 9335 | 0.040 |
Why?
|
China | 1 | 2004 | 2339 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1062 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2024 | 1157 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17624 | 0.040 |
Why?
|
Drug Combinations | 1 | 2003 | 2025 | 0.040 |
Why?
|
Heparin | 1 | 2004 | 1652 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2003 | 3602 | 0.030 |
Why?
|
Cytoplasm | 1 | 2021 | 1516 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3527 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2021 | 2753 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2021 | 2176 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2003 | 7850 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 2895 | 0.030 |
Why?
|
Lysine | 1 | 2021 | 1001 | 0.030 |
Why?
|
Catalase | 1 | 2016 | 216 | 0.030 |
Why?
|
Microfluidics | 1 | 2021 | 652 | 0.030 |
Why?
|
Cytokines | 1 | 2011 | 7343 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2011 | 14372 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6498 | 0.030 |
Why?
|
Cell Count | 1 | 2019 | 1835 | 0.030 |
Why?
|
Collagen | 1 | 2003 | 2636 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2012 | 5351 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2006 | 3446 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2222 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5899 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8515 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1664 | 0.030 |
Why?
|
Hepatocytes | 1 | 2020 | 1229 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6538 | 0.030 |
Why?
|
Blood Platelets | 1 | 2024 | 2520 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 732 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1885 | 0.030 |
Why?
|
Necrosis | 1 | 2016 | 1612 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2021 | 2907 | 0.020 |
Why?
|
Hemorrhage | 1 | 2024 | 3600 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4264 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 987 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 405 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1672 | 0.020 |
Why?
|
Proteome | 1 | 2021 | 1855 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1754 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1189 | 0.020 |
Why?
|
Antioxidants | 1 | 2016 | 1667 | 0.020 |
Why?
|
Anticoagulants | 1 | 2024 | 4897 | 0.020 |
Why?
|
Lactic Acid | 1 | 2012 | 1134 | 0.020 |
Why?
|
Cyclin B1 | 1 | 2006 | 58 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4107 | 0.020 |
Why?
|
Cyclin B | 1 | 2006 | 104 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6238 | 0.020 |
Why?
|
Mitotic Index | 1 | 2006 | 161 | 0.020 |
Why?
|
Lung | 1 | 2004 | 9994 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 11903 | 0.020 |
Why?
|
Chromosomal Instability | 1 | 2006 | 177 | 0.020 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2006 | 169 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7509 | 0.020 |
Why?
|
Absorption | 1 | 2004 | 243 | 0.010 |
Why?
|
Child, Preschool | 1 | 2007 | 42063 | 0.010 |
Why?
|
Biological Availability | 1 | 2004 | 395 | 0.010 |
Why?
|
Immunoblotting | 1 | 2006 | 1649 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2006 | 2471 | 0.010 |
Why?
|
Emphysema | 1 | 2004 | 240 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 58995 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1156 | 0.010 |
Why?
|
Mitosis | 1 | 2006 | 1191 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10756 | 0.010 |
Why?
|
India | 1 | 2006 | 2336 | 0.010 |
Why?
|
Child | 1 | 2007 | 79806 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15289 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 87810 | 0.010 |
Why?
|
Rabbits | 1 | 2004 | 4773 | 0.010 |
Why?
|
Phagocytosis | 1 | 2003 | 1535 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2003 | 2105 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29932 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3775 | 0.010 |
Why?
|
Aged | 1 | 2007 | 169152 | 0.010 |
Why?
|
Middle Aged | 1 | 2007 | 220352 | 0.010 |
Why?
|
Adult | 1 | 2007 | 219994 | 0.010 |
Why?
|
Thrombosis | 1 | 2004 | 3052 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 7593 | 0.010 |
Why?
|
Proteins | 1 | 2003 | 6029 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2003 | 12766 | 0.000 |
Why?
|